Renata M. Oballa

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Jacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 473 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

MS ^E with mass defect filtering for <i>in vitro</i> and <i>in vivo</i> metabolite identification

Kevin P. Bateman, José Castro‐Perez, Mark Wrona et al. · Rapid Communications in Mass Spectrometry · 2007 · 254 citations

Life Sciences, Pharmacokinetics, Pharmacology +14

Remote, 1,5-anti stereoinduction in the boron-mediated aldol reactions of β-oxygenated methyl ketones

Ian Paterson, Karl R. Gibson, Renata M. Oballa · Tetrahedron Letters · 1996 · 157 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12

Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity

Jean‐Pierre Falgueyret, Sylvie Desmarais, Renata M. Oballa et al. · Journal of Medicinal Chemistry · 2005 · 153 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds

Renata M. Oballa, Jean‐François Truchon, Christopher I. Bayly et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 147 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6